» Articles » PMID: 38254836

Expanding Our Knowledge of Gene Alterations and Their Role in Thyroid Diseases

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jan 23
PMID 38254836
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in , a gene involved in RNA interference, have been associated with a wide range of multi-organ neoplastic and non-neoplastic conditions. Historically known for its association with pleuropulmonary blastoma, DICER1 syndrome has received more attention due to the association with newly discovered diseases and tumors. Recent studies evaluating mutations and DICER1-driven thyroid disease in both pediatric and adult thyroid nodules revealed thyroid disease as the most common manifestation of mutations. This study undertakes a comprehensive investigation into mutations, focusing on their role in thyroid diseases. Specific attention was given to thyroid follicular nodular disease and differentiated thyroid carcinomas in infancy as highly indicative of germline mutation or DICER1 syndrome. Additionally, poorly differentiated thyroid carcinoma and thyroblastoma were identified as potential indicators of somatic mutations. Recognizing these manifestations should prompt clinicians to expedite genetic evaluation for this neoplastic syndrome and classify these patients as high risk for additional multi-organ malignancies. This study comprehensively synthesizes the current knowledge surrounding this genetically associated entity, providing intricate details on histologic findings to facilitate its diagnosis.

Citing Articles

A Novel Pathogenic Variant of DICER1 Gene in a Young Greek Patient with 2 Different Sex-Cord Ovarian Tumors and Multinodular Goiter.

Roumpou A, Ieronimaki A, Manta A, Panayiotides I, Stratakis C, Kalantaridou S Int J Mol Sci. 2025; 26(5).

PMID: 40076617 PMC: 11900300. DOI: 10.3390/ijms26051990.


Ultrasound and histopathological assessment of benign, borderline, and malignant thyroid tumors in pediatric patients: an illustrative review and literature overview.

Janus D, Kujdowicz M, Kiszka-Wilkojc A, Kaleta K, Taczanowska-Niemczuk A, Radlinski J Front Endocrinol (Lausanne). 2025; 15:1481804.

PMID: 39950167 PMC: 11821508. DOI: 10.3389/fendo.2024.1481804.


Thyroid Cancer in Childhood Cancer Survivors: Demographic, Clinical, Germline Genetic Characteristics, Treatment, and Outcome.

Yildirim U, Kebudi R, Iribas Celik A, Zulfikar B, Kebudi A J Clin Med. 2025; 14(2).

PMID: 39860595 PMC: 11766211. DOI: 10.3390/jcm14020589.


DICER1: The Argonaute Endonuclease Family Member and Its Role in Pediatric and Youth Pathology.

Sergi C, Minervini F Biology (Basel). 2025; 14(1).

PMID: 39857323 PMC: 11761906. DOI: 10.3390/biology14010093.


Understanding the Dosage-Dependent Role of in Thyroid Tumorigenesis.

Rojo-Pardillo M, Godefroid L, Dom G, Lefort A, Libert F, Robaye B Int J Mol Sci. 2024; 25(19).

PMID: 39409030 PMC: 11476720. DOI: 10.3390/ijms251910701.


References
1.
Wasserman J, Sabbaghian N, Fahiminiya S, Chami R, Mete O, Acker M . DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2018; 103(5):2009-2015. DOI: 10.1210/jc.2017-02698. View

2.
Bignell G, Canzian F, Shayeghi M, Stark M, Shugart Y, Biggs P . Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet. 1997; 61(5):1123-30. PMC: 1716029. DOI: 10.1086/301610. View

3.
McClean G, Kurian S, Walter N, Kekre A, McCluggage W . Cervical embryonal rhabdomyosarcoma and ovarian Sertoli-Leydig cell tumour: a more than coincidental association of two rare neoplasms?. J Clin Pathol. 2007; 60(3):326-8. PMC: 1860567. DOI: 10.1136/jcp.2006.039206. View

4.
Hardin A, Hackell J . Age Limit of Pediatrics. Pediatrics. 2017; 140(3). DOI: 10.1542/peds.2017-2151. View

5.
Apellaniz-Ruiz M, de Kock L, Sabbaghian N, Guaraldi F, Ghizzoni L, Beccuti G . Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame deletion. Eur J Endocrinol. 2017; 178(2):K11-K19. DOI: 10.1530/EJE-17-0904. View